A Study of Necitumumab and Chemotherapy in Participants With Stage IV Squamous Non-Small Cell Lung Cancer
Clinical trial NCT01769391 · COMPLETED
Trial details
- NCT number
- NCT01769391
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2015-04-01
- Enrollment
- 167
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.